Avalon Investment & Advisory’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$410K Sell
2,957
-240
-8% -$32.3K 0.01% 267
2022
Q4
$433K Sell
3,197
-555
-15% -$69.6K 0.01% 261
2022
Q3
$412K Sell
3,752
-227
-6% -$28.8K 0.01% 245
2022
Q2
$526K Sell
3,979
-282
-7% -$37K 0.01% 230
2022
Q1
$565K Sell
4,261
-3,922
-48% -$470K 0.01% 239
2021
Q4
$953K Sell
8,183
-7,140
-47% -$840K 0.02% 211
2021
Q3
$1.84M Sell
15,323
-15,225
-50% -$1.77M 0.04% 197
2021
Q2
$3.66M Sell
30,548
-1,938
-6% -$213K 0.08% 161
2021
Q1
$3.23M Sell
32,486
-12,038
-27% -$1.21M 0.07% 161
2020
Q4
$4.45M Sell
44,524
-537
-1% -$56.9K 0.09% 140
2020
Q3
$4.94M Sell
45,061
-1,010
-2% -$112K 0.11% 129
2020
Q2
$4.87M Sell
46,071
-10,831
-19% -$1.12M 0.11% 129
2020
Q1
$5.08M Buy
56,902
+23,669
+71% +$2.23M 0.13% 136
2019
Q4
$3.31M Sell
33,233
-3,856
-10% -$363K 0.07% 182
2019
Q3
$3.31M Sell
37,089
-1,277
-3% -$111K 0.07% 176
2019
Q2
$3.17M Buy
38,366
+3,837
+11% +$301K 0.07% 179
2019
Q1
$2.79M Sell
34,529
-775
-2% -$61.1K 0.06% 194
2018
Q4
$2.68M Sell
35,304
-6,377
-15% -$498K 0.07% 188
2018
Q3
$3.3M Buy
41,681
+13,138
+46% +$994K 0.09% 196
2018
Q2
$2M Sell
28,543
-813
-3% -$58.5K 0.06% 224
2018
Q1
$2.05M Buy
29,356
+3,825
+15% +$265K 0.06% 211
2017
Q4
$1.77M Buy
25,531
+2,797
+12% +$189K 0.06% 211
2017
Q3
$1.54M Buy
22,734
+4,430
+24% +$280K 0.05% 204
2017
Q2
$1.25M Buy
18,304
+3,308
+22% +$216K 0.04% 229
2017
Q1
$934K Buy
+14,996
New +$873K 0.03% 252
2016
Q1
Sell
-7,098
Closed -$482K 262
2015
Q4
$482K Sell
7,098
-4,667
-40% -$306K 0.02% 207
2015
Q3
$749K Buy
11,765
+7,152
+155% +$471K 0.03% 171
2015
Q2
$294K Buy
+4,613
New +$316K 0.01% 236

Other funds holding AZN